West Ham to monitor Michail Antonio fitness this week ahead of Sheffield United trip

Michail Antonio is set to step up his recovery from a hamstring injury this week as he targets a return for West Ham against Sheffield United on Sunday. Antonio has missed two games since hurting his hamstring last month but he has made good progress over the international break. West […]

Michail Antonio is set to step up his recovery from a hamstring injury this week as he targets a return for West Ham against Sheffield United on Sunday.

Antonio has missed two games since hurting his hamstring last month but he has made good progress over the international break.

West Ham will closely monitor the 30-year-old in training this week and will not take any chances with a player who has struggled with hamstring injuries.

But it is hoped Antonio will be fit to face Sheffield United at Bramall Lane in what would be a significant boost for the Hammers.

Antonio has become a vital player for David Moyes. He was outstanding at the end of last season when he scored eight goals in seven games to help West Ham stay up, and he had scored three Premier League goals this season before his injury.

Gallery: Aston Villa Midweek Update: Jack Grealish, Louie Barry, Wesley & John Terry (Read Sport)

Speaking before the international break, Moyes suggested Antonio was not far away from a return.

“Mickey Antonio is doing much better and we hope he will be back shortly,” he said.

“We never put any schedule on it because Mickey is doing really well, he’s on the grass at the moment so we’re pleased.”  

Source Article

Next Post

Coronavirus drug combo, baricitinib plus remdesivir, gets FDA emergency approval

Sat Nov 21 , 2020
The U.S. Food and Drug Administration (FDA) on Thursday issued emergency approval to a drug combo to treat moderate to seriously ill coronavirus patients.  The combo, rheumatoid arthritis drug baricitinib plus Gilead’s remdesivir, was authorized to treat hospitalized patients 2 years or older requiring oxygen. The FDA said the drugs cut patients’ time […]
Coronavirus drug combo, baricitinib plus remdesivir, gets FDA emergency approval

You May Like